Publications: Miss Raine Astin-Chamberlain
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al.
(
2025
)
.
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
.
EClinicalMedicine
vol.
81
,
Astin-Chamberlain R, Pott J, Cole E, Bloom BM
(
2024
)
.
Sex and gender reporting in UK emergency medicine trials from 2010 to 2023: a systematic review
.
Emergency Medicine Journal
vol.
42
,
(
2
)
82
-
90
.
Boos J, van der Made CI, Ramakrishnan G, Coughlan E, Asselta R, Löscher B-S, Valenti LVC, de Cid R et al.
(
2024
)
.
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
.
Human Genetics and Genomics Advances
vol.
5
,
(
4
)
Bloom B, Fritz CL, Gupta S, Pott J, Skene I, Astin-Chamberlain R, Ali M, Thomas SA et al.
(
2024
)
.
Older age and risk for delayed abdominal pain care in the emergency department
.
European Journal of Emergency Medicine
vol.
31
,
(
5
)
332
-
338
.
Faust SN, Haynes R, Jones CE, Staplin N, Whittaker E, Jaki T, Juszczak E, Spata E et al.
(
2024
)
.
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet Child & Adolescent Health
vol.
8
,
(
3
)
190
-
200
.
Williams TC, Marlow R, Hardelid P, Lyttle MD, Lewis KM, Mpamhanga CD, Cunningham S, Roland D et al.
(
2023
)
.
Clinical Impact of Serious Respiratory Disease in Children Under the Age of 2 Years During the 2021–2022 Bronchiolitis Season in England, Scotland, and Ireland
.
The Journal of Infectious Diseases
vol.
230
,
(
1
)
e111
-
e120
.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al.
(
2023
)
.
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet Diabetes & Endocrinology
vol.
11
,
(
12
)
905
-
914
.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al.
(
2023
)
.
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
401
,
(
10387
)
1499
-
1507
.
Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, Abbasi S, Abbass H et al.
(
2022
)
.
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
.
The Lancet
vol.
400
,
(
10349
)
359
-
368
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2022
)
.
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
399
,
(
10325
)
665
-
676
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2021
)
.
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
399
,
(
10320
)
143
-
151
.
Bielicki JA, Stöhr W, Barratt S, Dunn D, Naufal N, Roland D, Sturgeon K, Finn A et al.
(
2021
)
.
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia
.
JAMA
vol.
326
,
(
17
)
1713
-
1724
.
Gray AJ, Roobottom C, Smith JE, Goodacre S, Oatey K, O’Brien R, Storey RF, Curzen N et al.
(
2021
)
.
Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial
.
The BMJ
vol.
374
,
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2021
)
.
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
.
The Lancet
vol.
397
,
(
10289
)
2049
-
2059
.
Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, Abbott A, Abdallah N et al.
(
2021
)
.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
397
,
(
10285
)
1637
-
1645
.
Abaleke E, Abbas M, Abbasi S, Abbott A, Abdelaziz A, Abdelbadiee S, Abdelfattah M, Abdul B et al.
(
2021
)
.
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
397
,
(
10274
)
605
-
612
.
Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, Walker S, Parkinson N et al.
(
2020
)
.
Genetic mechanisms of critical illness in COVID-19
.
Nature
vol.
591
,
(
7848
)
92
-
98
.